Patent · US Active

Composition for editing flavonoid biosynthetic gene by using CRISPR/Cas9 system, and use thereof

US12241071B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2019
Grant dateMar 4, 2025
Priority date—
Expiry dateApr 8, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/20
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present application relates to a method for inducing flavonoid biosynthetic gene-editing in a cell by using a CRISPR/CAS9 system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.